中财网 中财网股票行情
恒瑞医药(600276)财务分析指标    年份：
截止日期2026-03-312025-12-312025-09-302025-06-302025-03-31
营业总收入(万元)814056.533162941.622318808.191576119.36720561.11
营业收入(万元)814056.533162941.622318808.191576119.36720561.11
营业总成本(万元)566732.242320389.331694966.541089980.16512854.18
营业成本(万元)109094.91436265.58319544.12211496.22106866.25
净利润(万元)227000.23772204.70577085.74447655.04187650.22
归属于母公司的净利润(万元)228226.82771105.48575116.95445010.64187405.55
营业利润(万元)260744.35899000.28662451.24515889.27208598.09
利润总额(万元)255686.21870762.55641200.78505093.42207560.37
少数股东损益(万元)-127.35594.74906.56456.43238.64
基本每股收益(元)0.34(元)1.19(元)0.89(元)0.70(元)0.30(元)
稀释每股收益(元)0.34(元)1.18(元)0.89(元)0.70(元)0.30(元)
非经常性损益(万元)10986.9429764.9216181.98--1076.89
扣除非经常性损益后净利润(万元)217239.88741340.56558934.97427284.85186328.66
总资产(万元)7129386.246986731.586832754.056289351.715129278.17
总负债(万元)714677.62807049.24829502.25386371.91374301.26
归属于母公司股东权益合计(万元)6362626.446127206.865950425.085846483.124698705.95
股东权益合计(万元)6414708.636179682.346003251.805902979.804754976.91
实收资本(股本)(万元)663719.99663719.99663719.99663719.99637900.23
资本公积(万元)1288296.761293461.631293203.731287149.67285387.48
未分配利润(万元)4245562.314017335.483834256.843704150.523573958.45
经营活动产生的现金流量净额(万元)78644.591123537.81911043.03430045.3355517.41
经营活动现金流入小计(万元)692435.133483415.992697282.281612379.40630193.65
经营活动现金流出小计(万元)613790.542359878.181786239.251182334.08574676.24
投资活动产生的现金流量净额(万元)-72374.60-274050.24-152626.69-108473.29-53167.76
投资活动现金流入小计(万元)1137.2922140.3918819.5618283.2017035.43
投资活动现金流出小计(万元)73511.90296190.63171446.25126756.4970203.19
筹资活动产生的现金流量净额(万元)-18571.70778170.74809102.04803949.50-66105.92
筹资活动现金流入小计(万元)29953.421226567.911078027.321035193.79--
筹资活动现金流出小计(万元)48525.12448397.17268925.28231244.2966105.92
期末现金及现金等价物余额(万元)3968283.414015555.273976770.813554260.512363116.36
最后修改日期2026-04-232026-03-272025-10-282025-08-212025-04-25
↑返回页顶↑

转至恒瑞医药（600276）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。